title: Laser saphenous ablations in more than 1,000 limbs with long-term duplex examination follow-up.
abstract: BACKGROUND
  The goal of this study was to evaluate the duplex results of endovenous laser ablation in the treatment of incompetent great saphenous veins (GSV) and small saphenous veins (SSV) with at least 1-year follow-up.
  
  
  METHODS
  A retrospective registry was entered by 11 centers from Europe and America, organized by the International Endovenous Laser Working Group. Data concerning 1,020 limbs in patients with incompetence of the GSV and/or SSV, treated with the Endovenous Laser Ablation (EVLA) procedure, were collected. EVLA failures were defined on duplex imaging as reflux confined to the saphenofemoral or saphenopopliteal junction, reflux confined to the main saphenous trunk, or reflux of both junction and main trunk (totally patent saphenous vein) were analyzed at one or more years postoperatively.
  
  
  RESULTS
  The mean age of patients was 54 ± 5 years (range: 18-91 years). The average body mass index was 25. There was a paucity of severe complications: One case of third-degree skin burn, six patients with postsurgical deep vein thrombosis (0.6%), and 27 cases of sensory nerve damage (2.7%). At 1-year, the rate of complete occlusion of the saphenous trunk was 93.1%. There were 79 cases of treatment failures as evidenced by duplex: 22 isolated junction failures (2.2%), 44 isolated trunk failures (4.4%), and 13 totally patent veins (1.3%). Two-year duplex results were reported for 329 limbs with the identification of 19 new cases of failure. No new cases of failure were reported at 3-year follow-up of 130 limbs. Cumulative failure rates estimated by Kaplan-Meier analysis were 7.7% at 1-year and 13.1% at 2- and 3-year follow-up.
  
  
  CONCLUSIONS
  On the basis of a duplex scan performed at least 1-year post-treatment, this multicenter registry confirms the safety and efficacy of the EVLA procedure in the treatment of GSV and SSV reflux. Considering the continued failure rate documented in the present study, an annual follow-up by duplex is recommended to 2 years after EVLA.
authors.affiliation: Centro Multidisciplinare Day Surgery, Azienda Ospedaliera-Università, Padova, Italy.
authors.forename: Giorgio
authors.initials: G
authors.lastname: Spreafico
authors.forename: Lowell
authors.initials: L
authors.lastname: Kabnick
authors.forename: Todd L
authors.initials: TL
authors.lastname: Berland
authors.forename: Neal S
authors.initials: NS
authors.lastname: Cayne
authors.forename: Tom S
authors.initials: TS
authors.lastname: Maldonado
authors.forename: Glenn S
authors.initials: GS
authors.lastname: Jacobowitz
authors.forename: Caron R
authors.initials: CR
authors.lastname: Rockman
authors.forename: Pat J
authors.initials: PJ
authors.lastname: Lamparello
authors.forename: Ugo
authors.initials: U
authors.lastname: Baccaglini
authors.forename: Nung
authors.initials: N
authors.lastname: Rudarakanchana
authors.forename: Mark A
authors.initials: MA
authors.lastname: Adelman
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005060:Europe; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D053685:Laser Therapy / Q000009:adverse effects; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D012042:Registries; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012501:Saphenous Vein / Q000000981:diagnostic imaging / Q000601:surgery*; D013997:Time Factors; D016896:Treatment Outcome; D018616:Ultrasonography, Doppler, Duplex; D014481:United States; D014648:Varicose Veins / Q000000981:diagnostic imaging / Q000601:surgery*; D055815:Young Adult